CalciMedica, Inc.

Historical 13F Holders

Symbol
CALC
CUSIP
38942Q202
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 38942Q202 since 12/18/2024, largest first.

Filer % of Class Filed
Alafi Capital Co LLC 13D/A
19.9% 8/24/2026
Event 8/19/2026
Bering Partners II GP, L.L.C. 13D/A
10.0% 8/21/2026
Event 8/19/2026
Armistice Capital, LLC 13G
10.0% 8/14/2026
Event 6/30/2026
Woodline Partners LP 13G 8.1% 8/14/2026
Event 6/30/2026
Valence Investments SPV VI, LLC 13D/A
6.4% 6/30/2026
Event 6/25/2026
Stonepine Capital Management, LLC 13G
6.0% 8/25/2026
Event 8/19/2026
CVI Investments, Inc. 13G
5.1% 7/20/2026
Event 6/23/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Avenue Venture Opportunities Fund II, L.P. 13G/A
4.99% 6/25/2026
Event 6/23/2026
James E. Flynn 13G/A
4.3% 2/6/2026
Event 2/6/2026
Aisling Capital V, LP 13G/A
3.9% 3/3/2025
Event 3/3/2025
Soleus Private Equity Fund III, L.P. 13G/A
2.4% 5/8/2026
Event 3/31/2026
Chernett Jorey 13G/A 0% 5/20/2026
Event 3/31/2026
Revelation Healthcare Fund I, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 33 8.38 M $8.45 M
2026 Q1 28 1.10 M $593 k
2025 Q4 31 3.68 M $24.2 M
2025 Q3 31 3.57 M $10.9 M
2025 Q2 32 3.73 M $5.93 M
2025 Q1 31 3.97 M $7.49 M
2024 Q4 30 4.26 M $15.1 M
2024 Q3 26 3.06 M $13.6 M
2024 Q2 24 2.98 M $11.8 M
2024 Q1 24 3.55 M $14.8 M
2023 Q4 15 519 k $1.49 M
2023 Q3 16 759 k $1.99 M
2023 Q2 15 679 k $2.72 M